Neurotransmitters—key factors in neurological and neurodegenerative disorders of the central nervous system

RI Teleanu, AG Niculescu, E Roza… - International journal of …, 2022 - mdpi.com
Neurotransmitters are molecules that amplify, transmit, and convert signals in cells, having
an essential role in information transmission throughout the nervous system. Hundreds of …

Applications of various types of nanomaterials for the treatment of neurological disorders

A Waris, A Ali, AU Khan, M Asim, D Zamel, K Fatima… - Nanomaterials, 2022 - mdpi.com
Neurological disorders (NDs) are recognized as one of the major health concerns globally.
According to the World Health Organization (WHO), neurological disorders are one of the …

A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer's disease

N Rouhi, Z Chakeri, BG Nejad, M Rahimzadegan… - Heliyon, 2024 - cell.com
Alzheimer's disease (AD) is characterized by progressive neurodegeneration, memory loss,
and cognitive impairment leading to dementia and death. The blood-brain barrier (BBB) …

AGE-RAGE axis culminates into multiple pathogenic processes: A central road to neurodegeneration

R Bhattacharya, MR Alam, MA Kamal… - Frontiers in Molecular …, 2023 - frontiersin.org
Advanced glycation end-products (AGEs; eg, glyoxal, methylglyoxal or carboxymethyl-
lysine) are heterogenous group of toxic compounds synthesized in the body through both …

Evaluating the role of N-Acetyl-L-Tryptophan in the Aβ 1-42-induced neuroinflammation and cognitive decline in Alzheimer's disease

S Satarker, PC Gurram, A Nassar, S Manandhar… - Molecular …, 2024 - Springer
Abstract Alzheimer's disease (AD), a neurodegenerative condition previously known to affect
the older population, is also now seen in younger individuals. AD is often associated with …

Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability

Q Song, J Li, T Li, HW Li - Advanced Science, 2024 - Wiley Online Library
As a form of dementia, Alzheimer's disease (AD) suffers from no efficacious cure, yet AD
treatment is still imperative, as it ameliorates the symptoms or prevents it from deteriorating …

Exploitation of marine molecules to manage alzheimer's disease

M Silva, P Seijas, P Otero - Marine Drugs, 2021 - mdpi.com
Neurodegenerative diseases are sociosanitary challenges of today, as a result of increased
average life expectancy, with Alzheimer's disease being one of the most prevalent. This …

Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer's Disease: A Critical Review of New and Old Little Regarded Findings

A Atlante, D Valenti - International Journal of Molecular Sciences, 2023 - mdpi.com
Alzheimer's disease (AD) is the most common neurodegenerative disorder and the main
cause of dementia which is characterized by a progressive cognitive decline that severely …

Mechanisms involved in microglial-interceded Alzheimer's disease and nanocarrier-based treatment approaches

S Md, NA Alhakamy, MA Alfaleh, O Afzal… - Journal of Personalized …, 2021 - mdpi.com
Alzheimer's disease (AD) is a common neurodegenerative disorder accountable for
dementia and cognitive dysfunction. The etiology of AD is complex and multifactorial in …

Synthesis and biological evaluation of benzimidazoles/1, 3, 5-triazine-2, 4-diamine hybrid compounds: a new class of multifunctional alzheimer targeting agents

S Karimian, M Shekouhy, S Pirhadi, A Iraji… - New Journal of …, 2022 - pubs.rsc.org
In this study, a series of new benzimidazole/1, 3, 5-triazine-2, 4-diamine hybrid derivatives
(9a–9l) were designed and synthesized. The potential multi-target profiles of these …